RCUS icon

Arcus Biosciences

173 hedge funds and large institutions have $1.33B invested in Arcus Biosciences in 2022 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 64 increasing their positions, 32 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

16% less capital invested

Capital invested by funds: $1.59B → $1.33B (-$259M)

38% less funds holding in top 10

Funds holding in top 10: 85 (-3)

39% less call options, than puts

Call options by funds: $17.6M | Put options by funds: $28.9M

Holders
173
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$17.6M
Puts
$28.9M
Net Calls
Net Calls Change

Top Buyers

1 +$101M
2 +$42.7M
3 +$19.5M
4
Goldman Sachs
Goldman Sachs
New York
+$18.4M
5
FC
Finepoint Capital
Massachusetts
+$13.6M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$3.2M
52
$3.14M
53
$2.94M
54
$2.65M
55
$2.55M
56
$2.44M
57
$2.28M
58
$2.19M
59
$2.17M
60
$2.15M
61
$2.08M
62
$1.98M
63
$1.87M
64
$1.82M
65
$1.79M
66
$1.78M
67
$1.76M
68
$1.64M
69
$1.62M
70
$1.62M
71
$1.57M
72
$1.56M
73
$1.48M
74
$1.31M
75
$1.28M